-
1
-
-
11144241063
-
Galectins as modulators of tumour progression
-
Liu, F. T., and Rabinovich, G. A. (2005) Galectins as modulators of tumour progression. Nat. Rev. Cancer 5, 29-41
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 29-41
-
-
Liu, F.T.1
Rabinovich, G.A.2
-
2
-
-
82655173829
-
Galectin-3: A jack-of-all-trades in cancer
-
Newlaczyl, A. U., and Yu, L. G. (2011) Galectin-3: A jack-of-all-trades in cancer. Cancer Lett. 313, 123-128
-
(2011)
Cancer Lett.
, vol.313
, pp. 123-128
-
-
Newlaczyl, A.U.1
Yu, L.G.2
-
3
-
-
81255138301
-
Serum galectin-2,-4, and-8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium
-
Barrow, H., Guo, X., Wandall, H. H., Pedersen, J. W., Fu, B., Zhao, Q., Chen, C., Rhodes, J. M., and Yu, L. G. (2011) Serum galectin-2,-4, and-8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin. Cancer Res. 17, 7035-7046
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 7035-7046
-
-
Barrow, H.1
Guo, X.2
Wandall, H.H.3
Pedersen, J.W.4
Fu, B.5
Zhao, Q.6
Chen, C.7
Rhodes, J.M.8
Yu, L.G.9
-
4
-
-
0034101698
-
Concentrations of galectin-3 in the sera of normal controls and cancer patients
-
Iurisci, I., Tinari, N., Natoli, C., Angelucci, D., Cianchetti, E., and Iacobelli, S. (2000) Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin. Cancer Res. 6, 1389-1393
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 1389-1393
-
-
Iurisci, I.1
Tinari, N.2
Natoli, C.3
Angelucci, D.4
Cianchetti, E.5
Iacobelli, S.6
-
5
-
-
43149123081
-
Serum level of galectin-3 in human bladder cancer
-
Sakaki, M., Oka, N., Nakanishi, R., Yamaguchi, K., Fukumori, T., and Kanayama, H. O. (2008) Serum level of galectin-3 in human bladder cancer. J. Med. Invest. 55, 127-132
-
(2008)
J. Med. Invest.
, vol.55
, pp. 127-132
-
-
Sakaki, M.1
Oka, N.2
Nakanishi, R.3
Yamaguchi, K.4
Fukumori, T.5
Kanayama, H.O.6
-
6
-
-
47549102018
-
Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease
-
Saussez, S., Glinoer, D., Chantrain, G., Pattou, F., Carnaille, B., André, S., Gabius, H. J., and Laurent, G. (2008) Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease. Thyroid 18, 705-712
-
(2008)
Thyroid
, vol.18
, pp. 705-712
-
-
Saussez, S.1
Glinoer, D.2
Chantrain, G.3
Pattou, F.4
Carnaille, B.5
André, S.6
Gabius, H.J.7
Laurent, G.8
-
7
-
-
33646091536
-
High serum galectin-3 in advanced melanoma: Preliminary results
-
Vereecken, P., Zouaoui Boudjeltia, K., Debray, C., Awada, A., Legssyer, I., Sales, F., Petein, M., Vanhaeverbeek, M., Ghanem, G., and Heenen, M. (2006) High serum galectin-3 in advanced melanoma: preliminary results. Clin. Exp. Dermatol. 31, 105-109
-
(2006)
Clin. Exp. Dermatol.
, vol.31
, pp. 105-109
-
-
Vereecken, P.1
Zouaoui Boudjeltia, K.2
Debray, C.3
Awada, A.4
Legssyer, I.5
Sales, F.6
Petein, M.7
Vanhaeverbeek, M.8
Ghanem, G.9
Heenen, M.10
-
8
-
-
79251499303
-
Novel interaction of MUC4 and galectin: Potential pathobiological implications for metastasis in lethal pancreatic cancer
-
Senapati, S., Chaturvedi, P., Chaney, W. G., Chakraborty, S., Gnanapragassam, V. S., Sasson, A. R., and Batra, S. K. (2011) Novel interaction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clin. Cancer Res. 17, 267-274
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 267-274
-
-
Senapati, S.1
Chaturvedi, P.2
Chaney, W.G.3
Chakraborty, S.4
Gnanapragassam, V.S.5
Sasson, A.R.6
Batra, S.K.7
-
9
-
-
70149097554
-
Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface
-
Zhao, Q., Guo, X., Nash, G. B., Stone, P. C., Hilkens, J., Rhodes, J. M., and Yu, L. G. (2009) Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res. 69, 6799-6806
-
(2009)
Cancer Res.
, vol.69
, pp. 6799-6806
-
-
Zhao, Q.1
Guo, X.2
Nash, G.B.3
Stone, P.C.4
Hilkens, J.5
Rhodes, J.M.6
Yu, L.G.7
-
10
-
-
33846964873
-
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion
-
Yu, L. G., Andrews, N., Zhao, Q., McKean, D., Williams, J. F., Connor, L. J., Gerasimenko, O. V., Hilkens, J., Hirabayashi, J., Kasai, K., and Rhodes, J. M. (2007) Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J. Biol. Chem. 282, 773-781
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 773-781
-
-
Yu, L.G.1
Andrews, N.2
Zhao, Q.3
McKean, D.4
Williams, J.F.5
Connor, L.J.6
Gerasimenko, O.V.7
Hilkens, J.8
Hirabayashi, J.9
Kasai, K.10
Rhodes, J.M.11
-
11
-
-
84964411288
-
Interaction of the oncofetal Thomsen-Friedenreich antigen with galectins in cancer progression and metastasis
-
Sindrewicz, P., Lian, L.-Y., and Yu, L.-G. (2016) Interaction of the oncofetal Thomsen-Friedenreich antigen with galectins in cancer progression and metastasis. Front. Oncol. 6, 79
-
(2016)
Front. Oncol.
, vol.6
, pp. 79
-
-
Sindrewicz, P.1
Lian, L.-Y.2
Yu, L.-G.3
-
12
-
-
0032852259
-
MUC1 and cancer
-
Taylor-Papadimitriou, J., Burchell, J., Miles, D. W., and Dalziel, M. (1999) MUC1 and cancer. Biochim. Biophys. Acta 1455, 301-313
-
(1999)
Biochim. Biophys. Acta
, vol.1455
, pp. 301-313
-
-
Taylor-Papadimitriou, J.1
Burchell, J.2
Miles, D.W.3
Dalziel, M.4
-
13
-
-
77953627018
-
Interaction between circulating galectin-3 and cancerassociated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
-
Zhao, Q., Barclay, M., Hilkens, J., Guo, X., Barrow, H., Rhodes, J. M., and Yu, L. G. (2010) Interaction between circulating galectin-3 and cancerassociated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol. Cancer 9, 154
-
(2010)
Mol. Cancer
, vol.9
, pp. 154
-
-
Zhao, Q.1
Barclay, M.2
Hilkens, J.3
Guo, X.4
Barrow, H.5
Rhodes, J.M.6
Yu, L.G.7
-
14
-
-
84877097538
-
Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium
-
Chen, C., Duckworth, C. A., Zhao, Q., Pritchard, D. M., Rhodes, J. M., and Yu, L. G. (2013) Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium. Clin. Cancer Res. 19, 1693-1704
-
(2013)
Clin. Cancer Res.
, vol.19
, pp. 1693-1704
-
-
Chen, C.1
Duckworth, C.A.2
Zhao, Q.3
Pritchard, D.M.4
Rhodes, J.M.5
Yu, L.G.6
-
15
-
-
78650722060
-
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G-Ly6C granulocytes
-
Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., Bou-Reslan, H., Kallop, D., Weimer, R., Ludlam, M. J., Kaminker, J. S., et al. (2010) Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G-Ly6C granulocytes. Proc. Natl. Acad. Sci. U.S.A. 107, 21248-21255
-
(2010)
Proc. Natl. Acad. Sci. U.S.A.
, vol.107
, pp. 21248-21255
-
-
Kowanetz, M.1
Wu, X.2
Lee, J.3
Tan, M.4
Hagenbeek, T.5
Qu, X.6
Yu, L.7
Ross, J.8
Korsisaari, N.9
Cao, T.10
Bou-Reslan, H.11
Kallop, D.12
Weimer, R.13
Ludlam, M.J.14
Kaminker, J.S.15
-
16
-
-
0037435011
-
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
-
Wei, L. H., Kuo, M. L., Chen, C. A., Chou, C. H., Lai, K. B., Lee, C. N., and Hsieh, C. Y. (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22, 1517-1527
-
(2003)
Oncogene
, vol.22
, pp. 1517-1527
-
-
Wei, L.H.1
Kuo, M.L.2
Chen, C.A.3
Chou, C.H.4
Lai, K.B.5
Lee, C.N.6
Hsieh, C.Y.7
-
17
-
-
84873087237
-
CD146, a multi-functional molecule beyond adhesion
-
Wang, Z., and Yan, X. (2013) CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 330, 150-162
-
(2013)
Cancer Lett.
, vol.330
, pp. 150-162
-
-
Wang, Z.1
Yan, X.2
-
18
-
-
33947312169
-
Visualization of CD146 dimerization and its regulation in living cells
-
Bu, P., Zhuang, J., Feng, J., Yang, D., Shen, X., and Yan, X. (2007) Visualization of CD146 dimerization and its regulation in living cells. Biochim. Biophys. Acta 1773, 513-520
-
(2007)
Biochim. Biophys. Acta
, vol.1773
, pp. 513-520
-
-
Bu, P.1
Zhuang, J.2
Feng, J.3
Yang, D.4
Shen, X.5
Yan, X.6
-
19
-
-
84962045969
-
CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor
-
Nodomi, S., Umeda, K., Saida, S., Kinehara, T., Hamabata, T., Daifu, T., Kato, I., Hiramatsu, H., Watanabe, K. I., Kuwahara, Y., Iehara, T., Adachi, S., Konishi, E., Nakahata, T., Hosoi, H., and Heike, T. (2016) CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor. Oncogene 35, 5317-5327
-
(2016)
Oncogene
, vol.35
, pp. 5317-5327
-
-
Nodomi, S.1
Umeda, K.2
Saida, S.3
Kinehara, T.4
Hamabata, T.5
Daifu, T.6
Kato, I.7
Hiramatsu, H.8
Watanabe, K.I.9
Kuwahara, Y.10
Iehara, T.11
Adachi, S.12
Konishi, E.13
Nakahata, T.14
Hosoi, H.15
Heike, T.16
-
20
-
-
84947863810
-
The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma
-
Wang, J., Tang, X., Weng, W., Qiao, Y., Lin, J., Liu, W., Liu, R., Ma, L., Yu, W., Yu, Y., Pan, Q., and Sun, F. (2015) The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma. Oncogene 34, 5781-5795
-
(2015)
Oncogene
, vol.34
, pp. 5781-5795
-
-
Wang, J.1
Tang, X.2
Weng, W.3
Qiao, Y.4
Lin, J.5
Liu, W.6
Liu, R.7
Ma, L.8
Yu, W.9
Yu, Y.10
Pan, Q.11
Sun, F.12
-
21
-
-
84866343239
-
CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis
-
Jiang, T., Zhuang, J., Duan, H., Luo, Y., Zeng, Q., Fan, K., Yan, H., Lu, D., Ye, Z., Hao, J., Feng, J., Yang, D., and Yan, X. (2012) CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood 120, 2330-2339
-
(2012)
Blood
, vol.120
, pp. 2330-2339
-
-
Jiang, T.1
Zhuang, J.2
Duan, H.3
Luo, Y.4
Zeng, Q.5
Fan, K.6
Yan, H.7
Lu, D.8
Ye, Z.9
Hao, J.10
Feng, J.11
Yang, D.12
Yan, X.13
-
22
-
-
0028127225
-
MUC18, a melanomaprogression associated molecule, and its potential role in tumor vascularization and hematogenous spread
-
Sers, C., Riethmüller, G., and Johnson, J. P. (1994) MUC18, a melanomaprogression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res. 54, 5689-5694
-
(1994)
Cancer Res.
, vol.54
, pp. 5689-5694
-
-
Sers, C.1
Riethmüller, G.2
Johnson, J.P.3
-
23
-
-
0028330535
-
Isolation and functional characterization of the A32 melanoma-associated antigen
-
Shih, I. M., Elder, D. E., Speicher, D., Johnson, J. P., and Herlyn, M. (1994) Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res. 54, 2514-2520
-
(1994)
Cancer Res.
, vol.54
, pp. 2514-2520
-
-
Shih, I.M.1
Elder, D.E.2
Speicher, D.3
Johnson, J.P.4
Herlyn, M.5
-
24
-
-
78649883698
-
Circulating endothelial cells: Markers and mediators of vascular damage
-
Erdbruegger, U., Dhaygude, A., Haubitz, M., and Woywodt, A. (2010) Circulating endothelial cells: markers and mediators of vascular damage. Curr. Stem Cell Res. Ther. 5, 294-302
-
(2010)
Curr. Stem Cell Res. Ther.
, vol.5
, pp. 294-302
-
-
Erdbruegger, U.1
Dhaygude, A.2
Haubitz, M.3
Woywodt, A.4
-
25
-
-
84966349250
-
MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding
-
Ruma, I. M., Putranto, E. W., Kondo, E., Murata, H., Watanabe, M., Huang, P., Kinoshita, R., Futami, J., Inoue, Y., Yamauchi, A., Sumardika, I. W., Youyi, C., Yamamoto, K., Nasu, Y., Nishibori, M., et al. (2016) MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Clin. Exp. Metastasis 33, 609-627
-
(2016)
Clin. Exp. Metastasis
, vol.33
, pp. 609-627
-
-
Ruma, I.M.1
Putranto, E.W.2
Kondo, E.3
Murata, H.4
Watanabe, M.5
Huang, P.6
Kinoshita, R.7
Futami, J.8
Inoue, Y.9
Yamauchi, A.10
Sumardika, I.W.11
Youyi, C.12
Yamamoto, K.13
Nasu, Y.14
Nishibori, M.15
-
26
-
-
84962418452
-
CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
-
Jiang, G., Zhang, L., Zhu, Q., Bai, D., Zhang, C., and Wang, X. (2016) CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 35, 38
-
(2016)
J. Exp. Clin. Cancer Res.
, vol.35
, pp. 38
-
-
Jiang, G.1
Zhang, L.2
Zhu, Q.3
Bai, D.4
Zhang, C.5
Wang, X.6
-
27
-
-
84930417222
-
CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation
-
Jouve, N., Bachelier, R., Despoix, N., Blin, M. G., Matinzadeh, M. K., Poitevin, S., Aurrand-Lions, M., Fallague, K., Bardin, N., Blot-Chabaud, M., Vely, F., Dignat-George, F., and Leroyer, A. S. (2015) CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation. Int. J. Cancer 137, 50-60
-
(2015)
Int. J. Cancer
, vol.137
, pp. 50-60
-
-
Jouve, N.1
Bachelier, R.2
Despoix, N.3
Blin, M.G.4
Matinzadeh, M.K.5
Poitevin, S.6
Aurrand-Lions, M.7
Fallague, K.8
Bardin, N.9
Blot-Chabaud, M.10
Vely, F.11
Dignat-George, F.12
Leroyer, A.S.13
-
28
-
-
84863713142
-
Laminin-411 is a vascular ligand for MCAMand facilitates TH17 cell entry into the CNS
-
Flanagan, K., Fitzgerald, K., Baker, J., Regnstrom, K., Gardai, S., Bard, F., Mocci, S., Seto, P., You, M., Larochelle, C., Prat, A., Chow, S., Li, L., Vandevert, C., Zago, W., et al. (2012) Laminin-411 is a vascular ligand for MCAMand facilitates TH17 cell entry into the CNS. PLoS ONE 7, e40443
-
(2012)
PLoS ONE
, vol.7
, pp. e40443
-
-
Flanagan, K.1
Fitzgerald, K.2
Baker, J.3
Regnstrom, K.4
Gardai, S.5
Bard, F.6
Mocci, S.7
Seto, P.8
You, M.9
Larochelle, C.10
Prat, A.11
Chow, S.12
Li, L.13
Vandevert, C.14
Zago, W.15
-
29
-
-
84924521970
-
CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development
-
Tu, T., Zhang, C., Yan, H., Luo, Y., Kong, R., Wen, P., Ye, Z., Chen, J., Feng, J., Liu, F., Wu, J. Y., and Yan, X. (2015) CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development. Cell Res. 25, 275-287
-
(2015)
Cell Res.
, vol.25
, pp. 275-287
-
-
Tu, T.1
Zhang, C.2
Yan, H.3
Luo, Y.4
Kong, R.5
Wen, P.6
Ye, Z.7
Chen, J.8
Feng, J.9
Liu, F.10
Wu, J.Y.11
Yan, X.12
-
30
-
-
84873868361
-
The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells
-
Jouve, N., Despoix, N., Espeli, M., Gauthier, L., Cypowyj, S., Fallague, K., Schiff, C., Dignat-George, F., Vély, F., and Leroyer, A. S. (2013) The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J. Biol. Chem. 288, 2571-2579
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 2571-2579
-
-
Jouve, N.1
Despoix, N.2
Espeli, M.3
Gauthier, L.4
Cypowyj, S.5
Fallague, K.6
Schiff, C.7
Dignat-George, F.8
Vély, F.9
Leroyer, A.S.10
-
31
-
-
84966355939
-
Toll-like receptor 2 signalling: Significance in megakaryocyte development through Wnt signalling cross-talk and cytokine induction
-
Undi, R. B., Sarvothaman, S., Narasaiah, K., Gutti, U., and Gutti, R. K. (2016) Toll-like receptor 2 signalling: significance in megakaryocyte development through Wnt signalling cross-talk and cytokine induction. Cytokine 83, 245-249
-
(2016)
Cytokine
, vol.83
, pp. 245-249
-
-
Undi, R.B.1
Sarvothaman, S.2
Narasaiah, K.3
Gutti, U.4
Gutti, R.K.5
-
32
-
-
84929630175
-
A humanized monoclonal antibody against heat shock protein 60 suppresses murine arthritis and colitis and skews the cytokine balance toward an anti-inflammatory response
-
Ulmansky, R., Landstein, D., Moallem, E., Loeb, V., Levin, A., Meyuhas, R., Katzavian, G., Yair, S., and Naparstek, Y. (2015) A humanized monoclonal antibody against heat shock protein 60 suppresses murine arthritis and colitis and skews the cytokine balance toward an anti-inflammatory response. J. Immunol. 194, 5103-5109
-
(2015)
J. Immunol.
, vol.194
, pp. 5103-5109
-
-
Ulmansky, R.1
Landstein, D.2
Moallem, E.3
Loeb, V.4
Levin, A.5
Meyuhas, R.6
Katzavian, G.7
Yair, S.8
Naparstek, Y.9
-
33
-
-
84925632944
-
Sweet role of platelet endothelial cell adhesion molecule in understanding angiogenesis
-
Kitazume, S., Imamaki, R., Ogawa, K., and Taniguchi, N. (2014) Sweet role of platelet endothelial cell adhesion molecule in understanding angiogenesis. Glycobiology 24, 1260-1264
-
(2014)
Glycobiology
, vol.24
, pp. 1260-1264
-
-
Kitazume, S.1
Imamaki, R.2
Ogawa, K.3
Taniguchi, N.4
-
34
-
-
84997294263
-
IL-6 roles: Molecular pathway and clinical implication in pancreatic cancer: A systematic review
-
Pop, V. V., Seicean, A., Lupan, I., Samasca, G., and Burz, C. C. (2017) IL-6 roles: molecular pathway and clinical implication in pancreatic cancer: A systematic review. Immunol. Lett. 181, 45-50
-
(2017)
Immunol. Lett.
, vol.181
, pp. 45-50
-
-
Pop, V.V.1
Seicean, A.2
Lupan, I.3
Samasca, G.4
Burz, C.C.5
-
35
-
-
77950690023
-
Interleukin-6 in bone metastasis and cancer progression
-
Ara, T., and Declerck, Y. A. (2010) Interleukin-6 in bone metastasis and cancer progression. Eur. J. Cancer 46, 1223-1231
-
(2010)
Eur. J. Cancer
, vol.46
, pp. 1223-1231
-
-
Ara, T.1
Declerck, Y.A.2
-
36
-
-
84943426117
-
Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
-
Duckworth, C. A., Guimond, S. E., Sindrewicz, P., Hughes, A. J., French, N. S., Lian, L. Y., Yates, E. A., Pritchard, D. M., Rhodes, J. M., Turnbull, J. E., and Yu, L. G. (2015) Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. Oncotarget 6, 23671-23687
-
(2015)
Oncotarget
, vol.6
, pp. 23671-23687
-
-
Duckworth, C.A.1
Guimond, S.E.2
Sindrewicz, P.3
Hughes, A.J.4
French, N.S.5
Lian, L.Y.6
Yates, E.A.7
Pritchard, D.M.8
Rhodes, J.M.9
Turnbull, J.E.10
Yu, L.G.11
|